Background Image
Table of Contents Table of Contents
Previous Page  182 / 658 Next Page
Information
Show Menu
Previous Page 182 / 658 Next Page
Page Background

4

LC-MS Quantitative Screening Method for 18 Anabolic Steroids in Oral Fluid Using MS2 Spectra Data Collected with Q Exactive Orbitrap Mass Spectrometer

tes collected for 1 ng/mL calibration standard

S2 spectra (Figure 2) were selected for

calculated and EU guidelines

1

for

m/z in MS

source

Ret Time

(min)

Fragment

1

Fragment

2

69 259.0763

3.2

203.0129 132.0679

62 259.2056

7.7

241.1942 145.1007

06 275.2006

6.5

109.0647 83.0494

61 283.2056

6.6

173.0956 147.0800

55 285.1849

4.3

121.0645 147.0798

06 287.2006

6.2

121.0648 135.1166

62 287.2006

7.2

97.0653 109.0651

68 289.2162

6.4

135.1165 121.1012

62 289.2162

6.9

97.0651 109.0650

62 289.2162

7.4

97.0651 109.0650

55 303.1955

4.2

121.0649 171.0802

87 311.2482

7.6

81.0542 107.0857

62 313.2162

7.9

241.1576 159.0798

68 319.2268

7.2

113.0595 125.0593

72 323.1772

7.5

143.0254 131.0254

73 337.2173

6.4

241.1576 131.0851

36 345.2536

6.3

97.0400 107.0855

22 353.2123

4.7

95.0857 239.1419

63 292.2263

6.9

100.0753 112.0751

rent ion and fragments in MS2 spectrum

3

4

5

6

7

8

Time (min)

0

50

100

0

50

100

0

50

100

0

50

100

Relative Abundance

0

50

100

0

50

100 RT:3.17

RT:7.56

RT:6.51

6.88

RT:6.58

RT:4.31

RT:6.20

4

5

6

7

8

Time (min)

0

50

100

0

50

100

0

50

100

0

50

100

Relative Abundance

0

50

100

0

50

100

RT:7.10

RT:6.33

RT:6.88

RT:7.23

RT:4.33

4.51

4.23

RT:7.41

RT:6.88

5

6

7

8

Time (min)

0

50

100

0

50

100

0

50

100

0

50

100

Relative Abundance

0

50

100

0

50

100

RT:7.75

RT:7.09

RT:7.39

RT:6.36

RT:6.12

RT:4.74

Clenbuterol

19-Norandrosterone

*

Nandrolone

Methandrosterone

6

β

-Hydroxyboldenone

Boldenone

Testosterone

13

C

3

Stanozolol

Formestane

Testosterone

Epitestosterone

Oxandrolone

DHEA

THG

Oxymesterone

Clostebol

Fluoxymesterone

3-Hydroxystanozolol

**

6

β

-Hydroxyfluoxymesterone

Linearity Range, LOQ, LOD

Table 2. Linearity ranges, LOQ, LOD

Analyte

Linearity range

R

2

LOQ

LOD

Clenbuterol

1-150 ng/mL

0.9981

1 ng/mL

<1 ng/mL

19-Norandrosterone

1-1500 ng/mL 0.9937

1 ng/mL

< 1 ng/mL

Nandrolone

3-150 ng/mL

0.9926

3 ng/mL

<1 ng/mL

Methandrosterone

1-600 ng/mL

0.9931

1 ng/mL

<1 ng/mL

6

β

-Hydroxyboldenone

1-600 ng/mL

0.9852

1 ng/mL

<1 ng/mL

Boldenone

1-600 ng/mL

0.9939

1 ng/mL

<1 ng/mL

DHEA

1-600 ng/mL

0.9898

1 ng/mL

<1 ng/mL

Oxandrolone

1-1500 ng/mL 0.9905

1 ng/mL

<1 ng/mL

Testosterone

1-300 ng/mL

0.9896

1 ng/mL

<1 ng/mL

Epitestosterone

1-600 ng/mL

0.9889

1 ng/mL

<1 ng/mL

Formestane

1-600 ng/mL

0.9882

1 ng/mL

<1 ng/mL

Stanozolol

1-300 ng/mL

0.9911

1 ng/mL

<1 ng/mL

THG

1-600 ng/mL

0.9914

1 ng/mL

<1 ng/mL

Oxymesterone

1-300 ng/mL

0.9923

1 ng/mL

<1ng/mL

Clostebol

1-150 ng/mL

0.9961

1 ng/mL

<1 ng/mL

Fluoxymesterone

1-300 ng/mL

0.9916

1 ng/mL

<1 ng/mL

3-Hydroxystanozolol

1-60 ng/mL

0.9952

1 ng/mL

<1 ng/mL

6

β

-Hydroxyfluoxymesterone

6-150 ng/mL

0.9838

6 ng/mL

3 ng/mL

Method Precision

QC samples with concentrations a

450 ng/mL) were prepared in blan

separate batches to obtain intra- a

Figure 3. Chromatographic peaks reconstructed with m/z accuracy of 5 ppm at LOQ

of 1 ng/mL (*3 ng/mL, **6 ng/mL)

Matrix Effect

Matrix effects (Table 4) were eval

concentrations of 2 ng/mL, 10 ng

calibration standards prepared in

Analyte

Clenbuterol

19-Norandrosterone

Nandrolone

Methandrosterone

6

β

-Hydroxyboldenone

Boldenone

DHEA

Oxandrolone

Testosterone

Epitestosterone

Formestane

Stanozolol

THG

Oxymesterone

Clostebol

Fluoxymesterone

3-Hydroxystanozolol

6

β

-Hydroxufluoxymesterone

ND: not detected; *concentration (1.61 ng

1ng

RT:

6.37

AV:

1

NL:

6.19E4

F:

TMS+pAPCI corona

Fullms2275.20@hcd5

0.00 [50.00-580.00]

70 80 90 100 110 120 130 140 150 160 170 180 190 200

m/z

0

10

20

30

40

50

60

70

80

90

100

Relative Abundance

109.0650

83.0497

145.1010

81.0704 93.0702

133.1010

105.0702

119.0856

187.1478

149.1323

199.1479

79.0547

173.1321

163.1115

69.0705

Qualifier

Quantifier

Nandrolone

Figure 4. Calibration curves for selected analytes

Table 3. Intra-assay and inter-a

Table 4. Percent recovery in sp

Analyte

2 ng/mL 15

Clenbuterol

<10.5

19-Norandrosterone

<12.4 <

Nandrolone

NA

Methandrosterone

<13.1 <

6

β

-Hydroxyboldenone

<7.9

<

Boldenone

<15.1

DHEA

<16.6 <

Oxandrolone

<11.0 <

Testosterone

<14.6

Epitestosterone

<16.4 <

Formestane

<10.4 <

Stanozolol

<20.9 <

THG

<19.5 <

Oxymesterone

<25.0

Clostebol

<14.8 <

Fluoxymesterone

<18.0

3-Hydroxystanozolol

<15.1

6

β

-Hydroxyfluoxymesterone

NA

<